Showing content from https://pubmed.ncbi.nlm.nih.gov/27753435/ below:
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Review
doi: 10.1038/ajg.2016.492. Epub 2016 Oct 18. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Affiliations
Affiliations
- 1 VA Medical Center, White River Junction, Vermont, USA.
- 2 Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
- 3 University of California, San Francisco Medical Center, San Francisco, California, USA.
- 4 Baylor University Medical Center, Dallas, Texas, USA.
- 5 VA Puget Sound Health Care System, University of Washington School of Medicine, Seattle, Washington, USA.
- 6 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- 7 Eastern VA Medical School, Norfolk, Virginia, USA.
- 8 San Francisco Veterans Affairs Medical Center, University of California, San Francisco, California, USA.
- 9 Oregon Health and Science University, Portland, Oregon.
- 10 Kaiser Permanente Medical Center, Walnut Creek, California, USA.
- 11 Indiana University School of Medicine, Indianapolis, Indiana.
Item in Clipboard
Review
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Douglas J Robertson et al. Am J Gastroenterol. 2017 Jan.
doi: 10.1038/ajg.2016.492. Epub 2016 Oct 18. Affiliations
- 1 VA Medical Center, White River Junction, Vermont, USA.
- 2 Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
- 3 University of California, San Francisco Medical Center, San Francisco, California, USA.
- 4 Baylor University Medical Center, Dallas, Texas, USA.
- 5 VA Puget Sound Health Care System, University of Washington School of Medicine, Seattle, Washington, USA.
- 6 Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- 7 Eastern VA Medical School, Norfolk, Virginia, USA.
- 8 San Francisco Veterans Affairs Medical Center, University of California, San Francisco, California, USA.
- 9 Oregon Health and Science University, Portland, Oregon.
- 10 Kaiser Permanente Medical Center, Walnut Creek, California, USA.
- 11 Indiana University School of Medicine, Indianapolis, Indiana.
Item in Clipboard
Abstract
The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.
PubMed Disclaimer
Similar articles
- Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Robertson DJ, et al. Gastroenterology. 2017 Apr;152(5):1217-1237.e3. doi: 10.1053/j.gastro.2016.08.053. Epub 2016 Oct 19. Gastroenterology. 2017. PMID: 27769517 Review.
- Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer.
Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK. Robertson DJ, et al. Gastrointest Endosc. 2017 Jan;85(1):2-21.e3. doi: 10.1016/j.gie.2016.09.025. Epub 2016 Oct 18. Gastrointest Endosc. 2017. PMID: 27769516 Review. No abstract available.
References
-
- Eur J Gastroenterol Hepatol. 2014 Dec;26(12):1415-21 - PubMed
-
- Dig Liver Dis. 2012 Aug;44(8):694-9 - PubMed
-
- Gastroenterology. 2006 May;130(6):1872-85 - PubMed
-
- N Engl J Med. 2014 Apr 3;370(14 ):1287-97 - PubMed
-
- J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70 - PubMed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3